Summit Therapeutics PLC (NASDAQ:SMMT – Get Free Report) CEO Robert Duggan bought 100,000 shares of the firm’s stock in a transaction dated Thursday, June 4th. The shares were acquired at an average price of $14.60 per share, with a total value of $1,460,000.00. Following the purchase, the chief executive officer directly owned 25,824,474 shares of […]

Summit Therapeutics PLC (NASDAQ:SMMT – Get Free Report) CFO Manmeet Singh Soni bought 50,000 shares of the business’s stock in a transaction that occurred on Thursday, June 4th. The shares were acquired at an average price of $14.45 per share, for a total transaction of $722,500.00. Following the completion of the transaction, the chief financial […]

Rein Therapeutics Inc. (NASDAQ:RNTX – Get Free Report) Director Rickenbach Josef Von purchased 15,950 shares of Rein Therapeutics stock in a transaction that occurred on Friday, May 22nd. The stock was acquired at an average cost of $1.05 per share, with a total value of $16,747.50. Following the acquisition, the director directly owned 34,824 shares […]